Dr Reddy’s Accuses Amarin Of ‘Illegally’ Blocking Vascepa API Supply
Indian Firm Has Sued Originator In A New Jersey Court
Having sat on an approved Vascepa ANDA since August last year, Dr Reddy’s Laboratories has sued originator Amarin, claiming the firm has illegally cornered the market for the hard-to-manufacture active ingredient.
